MARSTON FOREST HEALTHCARE — All Prescriptions & Medications — Page 4
Practice Code: E81043 | BEDFORD, MK43 0LA
Showing results 151-200 of 594
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Acetylcysteine | 190 | 5,640 | £985 | +165.8% ▲ |
| Sacubitril/valsartan | 188 | 10.4K | £17.0K | -21.5% ▼ |
| Azithromycin | 188 | 4,032 | £1.1K | +48.3% ▲ |
| Lisdexamfetamine dimesylate | 187 | 4,894 | £11.3K | +56.6% ▲ |
| Rivaroxaban | 185 | 5,177 | £2.7K | -69.8% ▼ |
| Ranolazine | 182 | 10.7K | £2.0K | +7.1% ▲ |
| Irbesartan | 181 | 5,632 | £215 | -25.7% ▼ |
| Mometasone furoate | 181 | 14.8K | £1.4K | +35.4% ▲ |
| Diclofenac diethyl | 180 | 22.5K | £2.1K | -49.3% ▼ |
| 178 | 2,065 | £457 | -14.8% ▼ | |
| Risperidone | 173 | 8,783 | £1.5K | -31.6% ▼ |
| Sodium valproate | 173 | 25.7K | £1.9K | -45.6% ▼ |
| Bimatoprost | 173 | 2,070 | £1.8K | +16.4% ▲ |
| Tadalafil | 172 | 2,280 | £463 | +1.2% vs avg |
| Etoricoxib | 171 | 5,824 | £1.2K | +112.2% ▲ |
| Calcipotriol | 170 | 14.0K | £7.4K | -0.1% vs avg |
| Biphasic isophane insulin | 168 | 1,239 | £5.3K | +50.6% ▲ |
| Dorzolamide and timolol | 168 | 2,690 | £2.1K | +17.4% ▲ |
| Tirzepatide | 167 | 167 | £16.2K | -14.0% ▼ |
| Verapamil hydrochloride | 165 | 11.2K | £648 | +81.9% ▲ |
| Paroxetine hydrochloride | 165 | 5,317 | £199 | -11.6% ▼ |
| Buprenorphine | 162 | 828 | £2.7K | -55.8% ▼ |
| Hyoscine butylbromide | 161 | 16.1K | £1.9K | -30.9% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 161 | 18.2K | £1.5K | -28.8% ▼ |
| Aciclovir | 161 | 5,710 | £348 | +8.2% ▲ |
| Zolpidem tartrate | 160 | 4,466 | £183 | +77.6% ▲ |
| Dulaglutide | 158 | 636 | £11.6K | +37.9% ▲ |
| Insulin glargine | 157 | 757 | £6.7K | -44.7% ▼ |
| Letrozole | 156 | 4,364 | £392 | -16.5% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 154 | 8,141 | £580 | +0.8% vs avg |
| Linagliptin | 153 | 4,032 | £4.6K | -62.6% ▼ |
| Clobetasone butyrate | 153 | 8,860 | £1.3K | -25.0% ▼ |
| Ropinirole hydrochloride | 152 | 8,568 | £4.1K | +43.1% ▲ |
| 151 | 15.9K | £1.4K | +219.8% ▲ | |
| Topiramate | 146 | 11.7K | £667 | -17.8% ▼ |
| Isophane insulin | 144 | 671 | £2.9K | +36.4% ▲ |
| Aripiprazole | 142 | 5,054 | £743 | -44.2% ▼ |
| Fluticasone propionate (Nasal) | 141 | 468 | £1.6K | -3.2% ▼ |
| Fluticasone/umeclidinium/vilanterol | 140 | 140 | £5.9K | -40.3% ▼ |
| Ciprofloxacin | 135 | 3,760 | £396 | +238.5% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 132 | 137 | £1.9K | +16.4% ▲ |
| 132 | 138 | £957 | -44.1% ▼ | |
| Mometasone furoate | 130 | 133 | £1.0K | -67.6% ▼ |
| Meloxicam | 129 | 4,462 | £126 | +95.0% ▲ |
| Prochlorperazine maleate | 128 | 4,368 | £418 | -36.7% ▼ |
| Brinzolamide | 128 | 965 | £703 | -1.5% vs avg |
| Sulfasalazine | 127 | 15.5K | £3.5K | -2.4% ▼ |
| Metoclopramide hydrochloride | 127 | 10.7K | £504 | +53.3% ▲ |
| Powder extensively hydrolysed formula (0913101) | 126 | 384.4K | £11.2K | +74.9% ▲ |
| Clotrimazole | 124 | 1,177 | £1.3K | +12.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.